Interim analysis of post-marketing surveillance of omalizumab in Japan

K. Ohta, H. Yoshisue, Y. Aoki, T. Irokawa, M. Ishigaki, M. Adachi, T. Miyamoto (Tokyo, Japan)

Source: Annual Congress 2013 –Asthma drugs: new findings
Session: Asthma drugs: new findings
Session type: Thematic Poster Session
Number: 4128
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Ohta, H. Yoshisue, Y. Aoki, T. Irokawa, M. Ishigaki, M. Adachi, T. Miyamoto (Tokyo, Japan). Interim analysis of post-marketing surveillance of omalizumab in Japan. Eur Respir J 2013; 42: Suppl. 57, 4128

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Asthma management in a specialist setting: Results of a national survey
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016


Priorities for asthma R&D in Europe: A systematic approach
Source: International Congress 2016 – Asthma points to ponder
Year: 2016


Asthma management among allergists in Italy: Results from a survey
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016


The Italian registry for severe/uncontrolled asthma
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016

Finding asthmatics suitable for omalizumab therapy in a district hospital
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013


Developing integrated mental health and asthma treatment protocol using quality improvement methods
Source: International Congress 2016 – Asthma points to ponder
Year: 2016


A national database study of the effectiveness of switching real-life asthma patients to fostair
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015


International perspectives on severe asthma: Current and future challenges in patient care
Source: International Congress 2016 – Asthma points to ponder
Year: 2016

Cost analysis of childhood asthma in Iran: A cost evaluation based on referral center data for asthma and allergies
Source: International Congress 2014 – More paediatric asthma
Year: 2014

A case diagnoed ACOS with omelizumab treatment
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016


Management of asthma in patients discharged from A and E
Source: International Congress 2016 – Asthma points to ponder
Year: 2016


A multidisciplinary clinic for children with severe asthma: Clinical outcomes and healthcare utilization
Source: International Congress 2014 – More paediatric asthma
Year: 2014

An overview of patient adherence to asthma medication in Canada
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013

Asthma therapeutic management in the elderly: Pharmacoepidemiological approach in the E3N cohort
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015

Cost-effectiveness of FeNO- and web-based monitoring in pediatric asthma management
Source: International Congress 2015 – Paediatric asthma and allergy: e-health in management
Year: 2015


Guideline adherence and cost of asthma treatment at emergency department
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014

Improving paediatric asthma management through improved communication
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014

LATE-BREAKING ABSTRACT: Effectiveness of individualized self management support for children with asthma in Dutch outpatient clinics, preliminary results of a randomized controlled trial.
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014

Safety and tolerability of acute dosing of beta-blockers in asthma
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013

Prevalence of asthma and management of exacerbations in general practice (GP) after computerised Spanish guideline on the management of asthma (GEMA) and collaborative care environment
Source: International Congress 2015 – Management of asthma and COPD in primary care
Year: 2015